US Patent Issued to JANSSEN SCIENCES IRELAND UNLtd. on May 12 for "Heterocyclic immunomodulators as PDL1 checkpoint inhibitor" (Belgian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,022, issued on May 12, was assigned to JANSSEN SCIENCES IRELAND UNLtd. COMPANY (County Cork, Ireland).

"Heterocyclic immunomodulators as PDL1 checkpoint inhibitor" was invented by David Craig McGowan (Beerse, Belgium) and Edgar Jacoby (Beerse, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure describes pyridinone-containing inhibitors of PD-L1, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds, and their use in the treatment of infectious diseases and cancer."

The patent was filed on June 5, 2020, under Application No. 17/595,711.

*For further information, including images, ...